{"transactions":[{"id":2311586,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":128544,"kind":"person","name":"De Groot Eleanor","position":1,"cik":"0001780420","reported_name":"De Groot Eleanor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-01T20:30:29.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three months after January 1, 2022, subject to the Reporting Person's continued service through each such date."}],"balance_after":350000,"derivative":{"exercise_price":0.66,"expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000899243-22-013117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322013117/doc4.xml","form_type":"4"}},{"id":2458775,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":128544,"kind":"person","name":"De Groot Eleanor","position":1,"cik":"0001780420","reported_name":"De Groot Eleanor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations"}}],"security":"Common Stock","published_at":"2021-12-27T17:20:38.000Z","date":"2021-12-22","kind":"sale","acquired":false,"shares":20132,"price":1.27,"value":25567.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding tax obligations upon the vesting of restricted stock grants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.25 to $1.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":237106,"source":{"system":"sec-edgar","filing":"0000899243-21-049739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924321049739/doc4.xml","form_type":"4"}},{"id":2803602,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":128544,"kind":"person","name":"De Groot Eleanor","position":1,"cik":"0001780420","reported_name":"De Groot Eleanor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM Cell Therapy"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-08T22:26:08.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":381188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/16th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2020."}],"balance_after":381188,"derivative":{"exercise_price":4.31,"expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":381188},"source":{"system":"sec-edgar","filing":"0001209191-21-018628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121018628/doc4.xml","form_type":"4"}},{"id":2803601,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":128544,"kind":"person","name":"De Groot Eleanor","position":1,"cik":"0001780420","reported_name":"De Groot Eleanor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM Cell Therapy"}}],"security":"Common Stock","published_at":"2021-03-08T22:26:08.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":50825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"12,707 shares shall vest on 12/31/2021 and 12,706 shares shall vest on each of 12/31/2022, 12/31/2023 and 12/31/2024."}],"balance_after":257238,"source":{"system":"sec-edgar","filing":"0001209191-21-018628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121018628/doc4.xml","form_type":"4"}},{"id":2916375,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":128544,"kind":"person","name":"De Groot Eleanor","position":1,"cik":"0001780420","reported_name":"De Groot Eleanor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM Cell Therapy"}}],"security":"Common Stock","published_at":"2021-01-06T22:03:45.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":21620,"price":2.72,"value":58806.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding tax obligations upon the vesting of restricted stock grants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":206413,"source":{"system":"sec-edgar","filing":"0001209191-21-002174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121002174/doc4.xml","form_type":"4"}},{"id":3296866,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":128544,"kind":"person","name":"De Groot Eleanor","position":1,"cik":"0001780420","reported_name":"De Groot Eleanor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM Cell Therapy"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-31T21:47:23.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":82600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2019."}],"balance_after":82600,"derivative":{"exercise_price":4.21,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":82600},"source":{"system":"sec-edgar","filing":"0001209191-20-005781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120005781/doc4.xml","form_type":"4"}},{"id":3296865,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":128544,"kind":"person","name":"De Groot Eleanor","position":1,"cik":"0001780420","reported_name":"De Groot Eleanor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM Cell Therapy"}}],"security":"Common Stock","published_at":"2020-01-31T21:47:23.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":53700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"17,900 shares shall vest on each of 12/31/2020, 12/31/2021 and 12/31/2022."}],"balance_after":228033,"source":{"system":"sec-edgar","filing":"0001209191-20-005781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120005781/doc4.xml","form_type":"4"}},{"id":3323839,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":128544,"kind":"person","name":"De Groot Eleanor","position":1,"cik":"0001780420","reported_name":"De Groot Eleanor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM Cell Therapy"}}],"security":"Common Stock","published_at":"2020-01-03T22:06:05.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":24890,"price":4.55,"value":113249.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding\ntax obligations upon the vesting of restricted stock grants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.46 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":174333,"source":{"system":"sec-edgar","filing":"0001209191-20-001170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120001170/doc4.xml","form_type":"4"}}]}